| Stage | XYZ | % of rev | ILMN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.6B | 100.00% | $1.1B | 100.00% | XYZ ×5.86 |
| Gross profit | $3.2B | 47.84% | $830M | 73.52% | ILMN +25.7pp |
| Operating income | $447M | 6.75% | $305M | 27.02% | ILMN +20.3pp |
| Pre-tax income | $301M | 4.56% | $264M | 23.38% | ILMN +18.8pp |
| Net income | $87M | 1.32% | $220M | 19.49% | ILMN +18.2pp |
| Stage | XYZ | ILMN | Gap · A − B |
|---|---|---|---|
| Revenue | $6.6B100.00% | $1.1B100.00% | XYZ ×5.86 |
| Gross profit | 47.84%$3.2B | 73.52%$830M | ILMN +25.7pp |
| Operating income | 6.75%$447M | 27.02%$305M | ILMN +20.3pp |
| Pre-tax income | 4.56%$301M | 23.38%$264M | ILMN +18.8pp |
| Net income |
| 1.32%$87M |
| 19.49%$220M |
| ILMN +18.2pp |
None
No disclosed counterparties: XYZ.